Intellectual Property India Publishes Patent Application for Fc Fragment Polypeptide For Producing Therapeutically Active Fusion Polypeptides And Conjugates

MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617070802 A) filed by Ooo Geropharm on June 06, 2026, for Fc Fragment Polypeptide For Producing Therapeutically Active Fusion Polypeptides And Conjugates.

Inventors include Rodionov, Petr Petrovich; Drai, Roman Vasilevich; Magruk, Maksim Andreevich; Latypov, Vitalii Feliksovich Number; Buslaeva, Evgeniia Aleksandrovna; Afanaseva, Alina Nikolaevna; Iashtubaeva, Anastasiia Dmitrievna; and Ishchuk, Sergei Aleksandrovich.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: The invention relates to the field of biotechnology, namely to the immunoglobulin Fc fragment polypeptides, and can be used for medical applications. The disclosed immunoglobulin Fc-fragment polypeptides having high binding capacity for FcRn and low binding capacity for Fc?Rs can be used for the production of therapeutically active fusion polypeptides and conjugates.

Disclaimer: Curated by HT Syndication.